Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zomedica Corp ZOM

Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic... see more

Recent & Breaking News (NYSEAM:ZOM)

Zomedica Announces Changes to Commercialization Leadership Team

GlobeNewswire June 14, 2018

Zomedica Pharmaceuticals Corp. Announces First Quarter 2018 Financial Results

GlobeNewswire May 15, 2018

Zomedica Announces Up to $10 Million Private Offering of Common Shares

GlobeNewswire May 15, 2018

Zomedica Signs Agreement With Seraph Biosciences for Innovative Veterinary Point-of-Care Diagnostic

GlobeNewswire May 10, 2018

Zomedica to Present at 2018 Disruptive Growth & Healthcare Conference

GlobeNewswire May 7, 2018

Zomedica to Present at 30th Annual ROTH Conference

GlobeNewswire March 7, 2018

Zomedica Pharmaceuticals Corp. Announces Year End 2017 Financial Results

GlobeNewswire February 28, 2018

Zomedica to participate in Merrill Lynch Animal Health Summit

Stockhouse Editorial February 20, 2018

Zomedica to Participate in the Bank of America Merrill Lynch Animal Health Summit

GlobeNewswire February 20, 2018

Zomedica Pharmaceuticals Corp. Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform

GlobeNewswire December 21, 2017

Zomedica Announces Achievement of Therapeutic Development Milestones

GlobeNewswire December 12, 2017

Zomedica commencing trading on NYSE American Exchange

Stockhouse Editorial November 21, 2017

Zomedica Pharmaceuticals Corp. Registration Statement Declared Effective by U.S. Securities and Exchange Commission

GlobeNewswire November 20, 2017

Zomedica Pharmaceuticals Corp. Expects Trading of its Common Shares on the NYSE American to Commence on November 21, 2017

GlobeNewswire November 16, 2017

Zomedica Pharma approved for listing by NYSE American

Stockhouse Editorial November 10, 2017

Zomedica Pharmaceuticals Corp. Announces NYSE American Listing Approval

GlobeNewswire November 10, 2017

Zomedica Pharmaceuticals Corp. Announces Third Quarter 2017 Financial Results

GlobeNewswire November 9, 2017

Zomedica Pharmaceuticals Corp. to Present at Jefferies 2017 London Healthcare Conference and LD Micro Main Event 2017

GlobeNewswire November 8, 2017

Zomedica Pharmaceuticals Corp. Announces US$5M Unsecured Working Capital Loan Facility

GlobeNewswire October 18, 2017

Zomedica Pharmaceuticals Corp. Amends Quorum Requirement for Shareholder Meetings

GlobeNewswire September 21, 2017